{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:45:29Z","timestamp":1774979129753,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1212\/wnl.51.4.962","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:36:31Z","timestamp":1336916191000},"page":"962-967","source":"Crossref","is-referenced-by-count":27,"title":["Creutzfeldt-Jakob disease"],"prefix":"10.1212","volume":"51","author":[{"given":"J.","family":"de Seze","sequence":"first","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Hache","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vermersch","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. F.","family":"Arndt","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Maurage","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pasquier","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Laplanche","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Ruchoux","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Leys","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Deste\u0301e","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Petit","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-ophthalmology (Drs. de Seze, Hache, and Arndt), Neurology (Drs. de Seze, Vermersch, Pasquier, Leys, Deste\u0301e, and Petit), and Neuropathology (Drs. Maurage and Ruchoux), Ho\u0302pital R. Salengro, Lille; and the Department of Biochemistry (Dr. Laplanche), Ho\u0302pital Lariboisie\u0300re, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1_Suppl_1.6S"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.Suppl.1"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197401032900102"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1996.00550010015001"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90001-6"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)98018-6"},{"key":"e_1_3_1_8_2","first-page":"9","volume":"335","year":"1996","unstructured":"Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924-930.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_9_2","first-page":"7","volume":"39","year":"1996","unstructured":"Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996;39:767-778.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_10_2","first-page":"1","volume":"43","year":"1993","unstructured":"Ripoll L, Laplanche JL, Salzmann M, et al. A new point mutation in the prion protein gene at codon 210 in Creutzfeldt-Jakob disease. Neurology 1993;43:1934-1938.","journal-title":"Neurology"},{"key":"e_1_3_1_11_2","first-page":"6","volume":"150","year":"1994","unstructured":"Brandel JP, Delasnerie-Laupretre N, Laplanche JL, Dormont D, Hauw JJ, Alperovitch A. R\u00e9seau d'\u00e9tudes des enc\u00e9phalopathies spongiformes humaines: premiers r\u00e9sultats. Rev Neurol 1994;150:684-688.","journal-title":"Rev Neurol"},{"key":"e_1_3_1_12_2","first-page":"5","volume":"20","year":"1986","unstructured":"Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986;20:597-602.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_13_2","first-page":"3","volume":"105","year":"1987","unstructured":"Rizzo M, Corbett JJ, Thompson HS. Is applanation tonometry a risk factor for transmission of Creutzfeldt-Jakob disease? Arch Ophthalmol 1987;105:314.","journal-title":"Is applanation tonometry a risk factor for transmission of Creutzfeldt-Jakob disease? Arch Ophthalmol"},{"key":"e_1_3_1_14_2","first-page":"2","volume":"9","year":"1989","unstructured":"Purvin V, Bonnin J, Goodman J. Palinopsia as a presenting manifestation of Creutzfeldt-Jakob disease. J Clin Neuro-Ophthalmol 1989;9:242-246.","journal-title":"J Clin Neuro-Ophthalmol"},{"key":"e_1_3_1_15_2","first-page":"4","volume":"119","year":"1995","unstructured":"Vargas ME, Kupersmith MJ, Savino PJ, Petito F, Frohman LP, Warren FA. Homonymous field defect as the first manifestation of Creutzfeldt-Jakob disease. Am J Ophthalmol 1995;119:497-504.","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(91)90186-B"},{"key":"e_1_3_1_17_2","first-page":"1","volume":"91","year":"1994","unstructured":"Richard P, Renault F, Ostre C, Auzoux-Cheve M. Neurophysiological follow-up in two children with Creutzfeldt-Jakob disease after human growth hormone treatment. Electroencephalogr Clin Neurophysiol 1994;91:100-107.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.1986.tb00676.x"},{"key":"e_1_3_1_19_2","first-page":"7","volume":"15","year":"1989","unstructured":"Curtis R, Fraser H, Forster JD, Scott JR. The correlation of electroretinographic and histopathological findings in the eyes of mice infected with the 79A strain of scrapie. Neuropathol Appl Neurobiol 1989;15:75-89.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00157133"},{"key":"e_1_3_1_21_2","first-page":"3","volume":"87","year":"1979","unstructured":"Lesser RL, Albert DM, Bobowick AR, O'Brien FH. Creutzfeldt-Jakob disease and optic atrophy. Am J Ophthalmol 1979;87:317-321.","journal-title":"Am J Ophthalmol"},{"key":"e_1_3_1_22_2","first-page":"1","volume":"30","year":"1990","unstructured":"Aguglia U, Farnarier G, Regis H, Oliveri RL, Quattrone A. Sensory evoked potentials in Creutzfeldt-Jakob disease. Eur Neurol 1990;30:157-161.","journal-title":"Eur Neurol"},{"key":"e_1_3_1_23_2","first-page":"2","volume":"108","year":"1985","unstructured":"Shibasaki H, Yamashita Y, Neshige R, Tobimatsu S, Fukui R. Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy. Brain 1985;108:225-240.","journal-title":"Brain"},{"key":"e_1_3_1_24_2","first-page":"4","volume":"90","year":"1994","unstructured":"Fukui R, Tobimatsu S, Kato M. Periodic synchronous discharges and visual evoked potentials in Creutzfeldt-Jakob disease: PSD-triggered flash VEPs. Electroencephalogr Clin Neurophysiol 1994;90:433-437.","journal-title":"Electroencephalogr Clin Neurophysiol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.4.962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:42:29Z","timestamp":1711550549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.4.962"}},"subtitle":["Neurophysiologic visual impairments"],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1212\/WNL.51.4.962"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.4.962","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}